BLOG

In Issue 7 of The Altascientist, we discuss how age, biological sex, genetics, and drug-drug interactions can affect drug metabolism and outcomes.

Discover how Altasciences reduced clinical trial start-up timelines by 70%, initiating the first dose of a Phase I MAD study in just 3.5 weeks.

Discover four key topics to expect to cover during your first meeting with a contract research organization, to set yourself up for a long-lasting partnership.

Liquid-filled capsules can be rapidly developed and tested, moving quickly from R&D to clinic. And scale-up of the manufacturing process for commercialization is straightforward. Read on for more advantages.

Explore the process required for manufacturing a highly potent API for an ophthalmic indication, based on a case study involving loteprednol etabonate, a topical corticosteroid used to treat eye inflammations.